Tessier cleft - Symptoms, Causes, Treatment & Prevention

```html Tessier Cleft – Comprehensive Medical Guide

Tessier Cleft – A Complete Patient‑Friendly Guide

Overview

Tessier clefts are a group of rare craniofacial anomalies that involve a cleft (or split) of the facial soft tissues, underlying bone, and sometimes the orbit (eye socket). The term comes from French surgeon Dr. Paul Tessier, who in the 1970s classified facial clefts based on their anatomic location using numbers 0–14. Unlike the more common “cleft lip/palate” (Tessier 0‑2), Tessier clefts often affect the lateral midline, the cheek, the orbital rim, or the forehead and can involve complex three‑dimensional deformities.

  • Who it affects: It occurs in both males and females, with a slight male predominance (≈55 %).
  • Prevalence: Overall incidence is estimated at 1‑4 per 100,000 live births, making it far less common than isolated cleft lip/palate (≈1 per 700 births).
  • Typical age of presentation: The defect is visible at birth, but the full extent may become clearer as the child grows.

Because the cleft can involve the orbit, dental arch, nasal cavity, and skull base, management usually requires a multidisciplinary team—including cranio‑facial surgeons, ophthalmologists, otolaryngologists, speech‑language pathologists, orthodontists, and psychologists.

Symptoms

The clinical picture varies widely depending on the Tessier number (the location of the cleft). Below is a comprehensive list of signs that may be present, grouped by anatomic region.

General facial findings

  • Visible soft‑tissue cleft: A groove, slit, or absent segment of skin/muscle on the cheek, temple, or forehead.
  • Asymmetry: One side of the face may appear flattened or displaced.
  • Abnormal hairline: Hair may be absent or ectopic near the cleft.

Orbital/orbital rim involvement (Tessier 3, 4, 5, 6, 7, 9, 10, 11, 12)

  • Enlarged or misshapen eye socket.
  • Epiphora (excess tearing) or epicanthal folds.
  • Strabismus (misalignment of the eyes).
  • Enophthalmos (sunken eye) or exophthalmos (protruding eye).
  • Exposure keratitis from inability to fully close the eyelid.

Nasal and midline findings (Tessier 0‑2, 13, 14)

  • Cleft lip or palate that may be isolated or combined with facial cleft.
  • Nasal deformity—e.g., flattened nasal bridge, columella deviation.
  • Choanal atresia (blocked nasal airway) in severe cases.

Dental and oral cavity symptoms

  • Missing, malformed, or ectopic teeth.
  • Maxillary (upper jaw) arch deficiency causing crossbite.
  • Difficulty feeding, especially in neonates.
  • Speech articulation problems once the child begins to talk.

Neurologic / cranial base findings

  • Presence of encephalocele (herniation of brain tissue) through the skull defect (rare, but reported with Tessier 1‑3).
  • Headaches or seizures if intracranial structures are involved.

Other possible symptoms

  • Hearing loss due to eustachian tube dysfunction.
  • Recurrent sinus infections.
  • Psychosocial impact—self‑esteem issues, social anxiety.

Causes and Risk Factors

Tessier clefts are considered sporadic in the vast majority of cases, but several genetic and environmental factors have been identified.

Genetic contributors

  • Chromosomal anomalies: 22q11.2 deletion syndrome (DiGeorge) and hemifacial microsomia have been linked to some lateral facial clefts.
  • Single‑gene mutations: Mutations in FGFR2, TP63, and IRF6 (genes also implicated in Van der Woude and Apert syndromes) can produce facial clefts that fall within the Tessier classification.
  • Familial clustering: Though rare, first‑degree relatives of an affected individual have a modestly increased risk (≈1–2 %).

Environmental risk factors

  • Maternal smoking or exposure to nicotine during the first trimester (OR ≈ 1.5).
  • Alcohol consumption > 2 drinks/day in early pregnancy (OR ≈ 1.8).
  • Maternal diabetes mellitus (especially uncontrolled) – increases overall craniofacial defect risk.
  • Use of certain medications (e.g., isotretinoin, phenytoin) known to be teratogenic.

Who is at higher risk?

  • Pregnant people with a family history of craniofacial anomalies.
  • Those with pre‑existing medical conditions that affect fetal development (e.g., diabetes, folate deficiency).
  • Women who are undernourished or have insufficient folic acid (< 400 µg/day) during peri‑conception.

Diagnosis

Because the defect is visible at birth, the initial suspicion is usually clinical. However, accurate classification and treatment planning require imaging and multidisciplinary assessment.

Clinical examination

  • Detailed cranio‑facial inspection (photography for documentation).
  • Palpation of bony landmarks to gauge skeletal involvement.
  • Ophthalmologic assessment for visual axis and globe position.
  • Dental evaluation for arch continuity and tooth eruption.

Imaging studies

  • CT scan with 3‑D reconstruction: Gold standard for bone anatomy, orbital involvement, and skull base defects.
  • MRI: Preferred when there is suspicion of encephalocele, vascular malformations, or soft‑tissue involvement.
  • Ultrasound: May be used in neonates to assess soft‑tissue cleft depth before CT is feasible.
  • Cephalometric radiographs: Help in orthodontic planning.

Genetic testing

If a syndromic pattern is suspected, clinicians may order chromosomal microarray, targeted gene panels, or whole‑exome sequencing. Results guide counseling and surveillance for associated anomalies (e.g., cardiac defects).

Functional assessments

  • Hearing test (ABR or tympanometry).
  • Speech‑language evaluation after the child begins vocalizing.
  • Vision testing by pediatric ophthalmology.

Treatment Options

Management is staged and individualized. The goal is to restore function (vision, feeding, speech), achieve facial symmetry, and address psychosocial wellbeing.

Non‑surgical interventions

  • Feeding support: Specialized bottles or nasogastric feeding if oral intake is compromised.
  • Speech therapy: Begins after palate repair or earlier if oral motor function is affected.
  • Ophthalmic care: Lubricating eye drops, protective goggles, or temporary tarsorrhaphy for exposure keratitis.
  • Psychological counseling: Early involvement helps reduce anxiety and improves coping.

Surgical reconstruction

Most patients undergo multiple procedures spaced over years, often coordinated by a cranio‑facial team.

  1. Early soft‑tissue closure (within the first 3‑6 months): Primary repair of the skin and musculature to protect underlying structures and improve aesthetics.
  2. Orbital reconstruction (usually 6 months – 2 years): Bone grafts (autologous rib or iliac crest) or resorbable plates to re‑establish orbital rim integrity; may be combined with medial canthoplasty.
  3. Cleft palate repair (if present): Performed around 9‑12 months of age, following the "rule of 10s" (10 weeks, 10 lb, hemoglobin > 10 g/dL).
  4. Midface advancement (late childhood to early teens): Distraction osteogenesis or Le Fort III osteotomy to correct maxillary deficiency and improve occlusion.
  5. Secondary aesthetic procedures (adolescence/adulthood): Scar revision, rhinoplasty, eyelid correction, and dental implants.

Medications

  • Antibiotics prophylaxis for surgeries involving the orbit or skull base.
  • Topical antibiotic ointments for postoperative wound care.
  • Analgesics (acetaminophen or ibuprofen) for pain control; opioids only short‑term if needed.

Lifestyle & supportive measures

  • Maintain good oral hygiene; children with dental anomalies need extra fluoride and regular orthodontic visits.
  • Avoid activities that risk facial trauma (e.g., contact sports) until skeletal repair is stable.
  • Regular nutrition monitoring to ensure adequate growth, especially if feeding was initially difficult.

Living with Tessier Cleft

While surgery can dramatically improve appearance and function, families often need ongoing support.

Practical daily tips

  • Feeding: Use angled bottles that reduce suction pressure; elevate the infant’s head slightly.
  • Oral care: Brush gently with a soft‑bristled brush twice daily; consider a fluoride rinse if recommended by the dentist.
  • Eye protection: Apply preservative‑free artificial tears every 2–3 hours if the eye does not close fully.
  • Skin care: Keep the cleft scar moisturized with silicone gel sheets or emollient creams to prevent cracking.
  • School & social life: Work with educators to arrange speech‑language sessions and to address potential bullying.

Psychosocial support

Connecting with patient advocacy groups—such as the Cleft Palate-Craniofacial Association (CPCA) or FACE (Facial Clefts Support Network)—offers peer mentorship, resource guides, and financial assistance for travel to specialty centers.

Long‑term follow‑up schedule (typical)

AgeKey Evaluations
0–6 monthsGrowth monitoring, feeding assessment, early ophthalmology.
6 months‑2 yearsFirst surgical repair, vision check, audiology.
2‑5 yearsSpeech evaluation, orthodontic screening.
6‑12 yearsMid‑face growth assessment, psychosocial screening.
AdolescenceFinal orthognathic surgery if needed, dental implants, transition to adult care.

Prevention

Because most Tessier clefts are sporadic, absolute prevention is not possible, but risk reduction strategies are well established.

  • Preconception folic acid: At least 400 µg daily, started 1 month before conception (WHO recommendation).
  • Control chronic conditions: Tight glycemic control for diabetes, avoid tobacco and alcohol.
  • Medication review: Discuss all prescription and over‑the‑counter drugs with a healthcare provider before pregnancy.
  • Environmental safety: Limit exposure to known teratogens (e.g., solvents, certain pesticides).
  • Genetic counseling: Recommended for couples with a personal or family history of craniofacial anomalies.

Complications

If left untreated or partially treated, Tessier clefts can lead to serious functional and psychosocial problems.

  • Vision loss: Due to exposure keratitis, strabismus, or orbital dysplasia.
  • Respiratory obstruction: Severe nasal or midline defects may impair airway patency.
  • Feeding failure & malnutrition: Persistent oral cavity defects hinder adequate intake.
  • Speech and hearing deficits: Resulting from palate involvement and eustachian tube dysfunction.
  • Dental malocclusion: Leads to temporomandibular joint disorders and increased caries risk.
  • Psychological sequelae: Low self‑esteem, social withdrawal, and increased rates of anxiety/depression.
  • Neurologic complications: Encephalocele or meningitis if skull base integrity is compromised.

When to Seek Emergency Care

Call 911 or go to the nearest emergency department if your child experiences any of the following:
  • Sudden loss of vision or severe eye pain.
  • Bleeding that won't stop after 10 minutes, especially from the cleft site.
  • Severe facial swelling, especially if associated with fever—possible infection or abscess.
  • Difficulty breathing or noisy/breathless breathing (stridor, choking).
  • High fever (> 38.5 °C) with lethargy—possible meningitis if a skull‑base defect is present.
  • Profound headache, vomiting, or seizures—signs of intracranial involvement.

Prompt evaluation can prevent permanent damage and reduce the risk of infection.


References: Mayo Clinic, CDC, NIH (National Institute of Dental and Craniofacial Research), WHO, Cleveland Clinic, and peer‑reviewed articles from Plastic and Reconstructive Surgery and The Cleft Palate-Craniofacial Journal. Data accessed July 2024.

```

⚠️ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.